WHO ICTRP trial
Assessment of Neurobiological Markers using different methodologies for…
EUCTR2011-004860-31-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-004860-31-AT |
|---|---|
| Public title | Assessment of Neurobiological Markers using different methodologies for Psychiatric Disorders |
| Scientific title | Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders - MAN-BIOPSY |
| Primary sponsor | Medical University of Vienna |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Austria |
| Conditions | Major Depressive Disorder Anxiety Disorder;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Interventions | Trade Name: Cipralex Product Name: Cipralex Pharmaceutical Form: Tablet INN or Proposed INN: ESCITALOPRAM CAS Number: 219861-08-2 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Trade Name: Cymbalta… |
| Registration date | Oct 14, 2011 |
| Target size | 0 |
| Secondary IDs | 2.2.20110919 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: